Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,555 active trials61 approved drugs296 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,964)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03692637 | Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer | unknown | Early Phase 1 | 30 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03561857 | Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology Surgery(PERSEE II) | unknown | N/A | 100 | Mauna Kea TechnologiesINDUSTRY | 1 | Jan 28, 2019 | clinicaltrials |
| NCT03459976 | HE4 is a Beneficial Biomarker in Endometrial Cancer(HE4) | unknown | — | 87 | Ain Shams UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03813576 | Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study | unknown | N/A | 300 | National University Hospital, SingaporeOTHER | 0 | Jan 23, 2019 | clinicaltrials |
| NCT03559803 | A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer | unknown | N/A | 58 | Sichuan UniversityOTHER | 1 | Jan 22, 2019 | clinicaltrials |
| NCT03253458 | Focal Prostate Imaging With CLE and OCT(FPI) | unknown | N/A | 14 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT03808792 | Imaging Study in Advanced Ovarian Cancer(ISAAC) | unknown | — | 400 | Charles University, Czech RepublicOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT02831920 | CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer | unknown | N/A | 299 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 17, 2019 | clinicaltrials |
| NCT03101176 | Multiparametric Ultrasound Imaging in Prostate Cancer | unknown | N/A | 200 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 17, 2019 | clinicaltrials |
| NCT03804463 | The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer | unknown | N/A | 170 | Min WangOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT03796299 | Expression of MCM5 in Urine in Patients With Urothelial Cancers | unknown | — | 180 | Medical University of WarsawOTHER | 1 | Jan 8, 2019 | clinicaltrials |
| NCT03793205 | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients | unknown | Phase 4 | 100 | Lei LiOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT01685190 | A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer(PIVOTAL) | unknown | Phase 2 | 124 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT03178136 | HR-HPV Multi-site Opportunistic Screening in Liaoning, China | unknown | — | 10,000 | Min WangOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03790384 | Sequential Combination Therapy in Bladder Cancer(MITOBCG) | unknown | Phase 4 | 140 | Azienda Ospedaliera "Sant'Andrea"OTHER | 0 | Dec 31, 2018 | clinicaltrials |
| NCT03188744 | Impact of Cancer Treatment on the Pelvic Floor Function in Survivors of Cervical Cancer | unknown | — | 150 | University of Sao PauloOTHER | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03553589 | Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma(BioEndoCar) | unknown | — | 400 | Andrea RomanoOTHER | 3 | Dec 5, 2018 | clinicaltrials |
| NCT03763123 | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. | unknown | Phase 1 | 48 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 4, 2018 | clinicaltrials |
| NCT03756207 | Multidisciplinary Bladder-preservation Therapy for Bladder Cancer | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT03740672 | Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline | unknown | — | 1,000 | Lei LiOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03744962 | MSI in Circulatory DNA of Endometrial Cancer | unknown | — | 100 | Lei LiOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03742388 | A Genomic Analysis of Evolution of Epithelia Ovarian Tumors | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03742856 | A Multi-omics Study of Epithelial Ovarian Cancer | unknown | — | 80 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03742869 | HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03738319 | Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer | unknown | — | 160 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03740464 | Long-acting G-CSF for Febrile Neutropenia | unknown | Phase 3 | 556 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03734614 | Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma | unknown | — | 260 | RenJi HospitalOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03110497 | Single Application Brachytherapy in Cervical Cancer | unknown | N/A | 40 | Tata Memorial HospitalOTHER_GOV | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03706508 | Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy | unknown | — | 120 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | unknown | N/A | 9,800 | Western Health and Social Care TrustOTHER | 1 | Oct 26, 2018 | clinicaltrials |
| NCT03709485 | Evaluation of Gut Microbiome in Patients With Prostate Cancer | unknown | N/A | 150 | Ziv HospitalOTHER_GOV | 0 | Oct 17, 2018 | clinicaltrials |
| NCT03630692 | Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs(TOPTACOS) | unknown | — | 158 | Institut Cancerologie de l'OuestOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT02913859 | Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer | unknown | Phase 2 | 60 | University Hospital Sestre MilosrdniceOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT03701659 | TUPKRP Combined With MAB Therapy for LUTS/PCa | unknown | N/A | 100 | The Third Xiangya Hospital of Central South UniversityOTHER | 0 | Oct 10, 2018 | clinicaltrials |
| NCT03696186 | Selective Treatment According to Molecular Subtype of Prostate Cancer(STAMP) | unknown | Phase 2 | 300 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02480790 | Venous Thromboembolic Complications in Ovarian Cancer | unknown | — | 98 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Oct 5, 2018 | clinicaltrials |
| NCT03252769 | Vaginal Self-sampling for Non-attenders | unknown | N/A | 1,950 | Western Health and Social Care TrustOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT02667431 | Cancer of the Uterus and Treatment of Stress Urinary Incontinence(CUTI) | unknown | — | 556 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03692000 | Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer(Emil2) | unknown | — | 55 | Danish Cancer SocietyOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03692533 | Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma | unknown | N/A | 80 | Assiut UniversityOTHER | 0 | Oct 2, 2018 | clinicaltrials |
| NCT03177551 | Predictive Nomogram of CRPC(CRPC-PN) | unknown | — | 300 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 1, 2018 | clinicaltrials |
| NCT03659110 | Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice | unknown | — | 1,000 | Beijing Chaoyang District Centre for Disease Control and PreventionOTHER | 0 | Sep 27, 2018 | clinicaltrials |
| NCT03687918 | External Validation of Prostate MRI QCAD/Lyon(DIJON-CAD) | unknown | — | 80 | Hospices Civils de LyonOTHER | 1 | Sep 27, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Feb 5, 2019source: clinicaltrials